Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
OPERATING ACTIVITIES
Net income	$ 1,430	$ 826
Adjustments to reconcile net income to net cash provided by operating activities:
Increase (decrease) in off-balance sheet reserves	243	(4)
Depreciation, amortization and accretion	845	1,421
Increase in cash surrender value of BOLI	(484)	(508)
Deferred income taxes	701	280
Stock-based compensation	720	553
Change in assets and liabilities which provided (used) cash:
Accrued interest receivable	(118)	(223)
Other assets	(150)	1,449
Other liabilities	(2,351)	(1,615)
Net cash provided by operating activities	836	2,179
INVESTING ACTIVITIES
Purchases of available-for-sale securities	(18,042)	(10,023)
Net purchase of restricted equity securities	(15)	(45)
Proceeds from maturities, prepayments or calls of investment securities available-for-sale	9,843	11,806
Proceeds from the sale of investment securities available-for-sale	6,206	168
Change in restricted cash	4,000
Net increase in loans	(314)	(29,348)
Purchases of bank properties and equipment	(186)	(747)
Proceeds from sale of real estate owned		266
Net cash provided by (used in) investing activities	1,492	(27,923)
FINANCING ACTIVITIES
Net decrease in deposits	(7,358)	(42,189)
Cash dividends paid to stockholders	(190)
Repayments of advances from FHLBNY	(49)	(47)
Repayment of obligations under capital leases	(105)	(99)
Proceeds from exercise of stock options	58	2
Net cash used in financing activities	(7,644)	(42,333)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(5,316)	(68,077)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	134,208	204,315
CASH AND CASH EQUIVALENTS, END OF PERIOD	128,892	136,238
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	2,940	$ 2,458
SUPPLEMENTAL DISCLOSURE OF NON-CASH ITEMS
Trade date liability on purchase of investment securities	$ 1,169